Patient Research
Find a studySpecialtiesConditionsTreatmentsBy countryLearn
Sign in
All treatments
Treatment

LENVATINIB, KEYTRUDA 25 mg/mL concentrate for solution for infusion., LENVATINIB clinical trials

1 indexed studies · 0 currently recruiting

  • AuthorisedTherapeutic exploratory (Phase II)

    A Phase II single arm open label study of Pembrolizumab and Lenvatinib in patients with high risk locally advanced cervix cancer: an EMBRACE high risk study initiative

    This study looks at two medicines, Lenvatinib and Keytruda, for women with a type of womb-neck cancer that is advanced or hasn't responded well to usual treatments. It's a Phase II study, meaning researchers are checking if these medicines together are a good option.

    For: high risk or poor response after chemoradiation and brachytherapy for locally advanced cervix cancer
    Netherlands
Advertisement
Advertisement
Advertisement
Patient.info Research

Find clinical research studies and trials explained in plain English - powered by Patient.info.

About
  • About us
  • Advertise with us
  • Partnerships
  • Authors
  • Contact us
Research explained
  • What is a clinical trial?
  • Trial phases explained
  • Why volunteer?
  • Clinical research FAQ
  • All health-research articles
Legal
  • About our content
  • Report a correction
  • Accessibility statement
  • Cookie policy
  • Privacy policy
  • Terms of use
  • Editorial policy
Find a study

Search clinical research studies and trials by condition, location and eligibility.

Browse studies →Learn about trials →
Information only. Research.Patient.info surfaces public clinical-trial registry data and explains it in plain English. We are not affiliated with the MHRA, HRA, NHS, NIHR or any regulator. Inclusion of a study is not an endorsement and is not medical advice — always discuss with your own doctor before agreeing to take part. See about our content or report a correction.
© 2026 Navigate Health Ltd. All rights reserved.
Registered number: 16229589
Registered office: 128 City Road, London, United Kingdom, EC1V 2NX.
Patient is a UK registered trade mark.
Patient does not provide medical advice, diagnosis or treatment.